Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Extraction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108948114B enables high-purity 9-(E)-erythromycin oxime via novel biphasic impurity removal, ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN115925534B reveals a pH-controlled extraction method achieving over 99% purity. This breakthrough offers significant cost reduction and supply chain reliability for global buyers.
Patent CN106117244A describes advanced purification for cephalosporins ensuring high purity and scalable manufacturing for reliable pharmaceutical intermediate supply chains globally.
Advanced supercritical CO2 purification method enhances Coenzyme Q10 purity and reduces solvent waste for sustainable pharmaceutical manufacturing supply chains.
Patent CN108059601A reveals high-yield synthesis for vildagliptin intermediate. Discover cost reduction in API intermediate manufacturing and supply chain reliability.
Advanced purification and cyclization patent CN115417755B ensures high purity furanone intermediates with optimized supply chain efficiency.
Patent CN108997376B reveals high-purity sulbactam acid production via recycling. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel purification method for paeoniflorin derivative ensures high purity and scalable production for pharmaceutical intermediates supply chain efficiency and cost reduction.
Patent CN112457307B details a biocatalytic extraction process achieving 100% optical purity. This method offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN101357903B details a novel extraction method for 4-formylaminoantipyrine, significantly improving purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN116162074A reveals a novel alcohol-washing purification method for 2,5-furandicarboxylic acid, significantly reducing acid consumption and waste treatment costs for bio-based polymer manufacturers.
Novel quaternary solvent system enables high purity Valganciclovir production with improved supply chain reliability and cost efficiency for global pharmaceutical manufacturers.
Patent CN108164398A details a novel reduction method eliminating column chromatography. This breakthrough ensures scalable production and substantial cost reduction for global supply chains.
Patent CN107602412A details a novel purification method for aldehyde oil methanol solution enhancing purity and solvent recovery for sustainable sulphadiazine intermediate manufacturing supply chains.
Patent CN113121558A reveals a novel purification method for Vitamin H intermediates, ensuring pharmaceutical grade purity without final product refinement.
Patent CN120794897A details a novel salifying extraction method for Evocalcet. This process ensures high purity and cost reduction in API manufacturing for global supply chains.
Patent CN101676293B details a novel indirect route for biimidazole phosphines, offering cost reduction in catalyst manufacturing and high-purity intermediates.
Patent CN107266301A reveals a novel solvent extraction method achieving over 99% purity for acetylacetonate salts, offering significant supply chain and cost advantages.